Genentech will invest approximately $750 million to double its Hillsboro, Oregon manufacturing campus with a new device fill-finish facility, adding 250 jobs as the company deepens its two-decade presence in the state amid a broader industry shift toward domestic drug production. Genentech is pouring $750 million into doubling the size of its Hillsboro, Oregon manufacturing […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
Portland renters filled nearly two apartments for every one the region delivered...
ByThe RegistryOctober 26, 2026A RISE Properties Trust affiliate has sold the 1978-built Northline Apartments on...
ByThe RegistryOctober 26, 2026With its ground floor nearly empty and upper floors less than half...
ByThe RegistryOctober 26, 2026Tacoma's South Sound CARE Foundation has filed land use plans for a...
ByThe RegistryOctober 26, 2026